SequelSEC

Sanara MedTech Inc. SMTI

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0000714256 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$28.14M
Fiscal year ended 2026-06-30
Operating income
$1.78M
Fiscal year ended 2026-06-30
Free cash flow
$2.03M
Fiscal year ended 2026-06-30

Sanara MedTech Inc. (SMTI) reported revenue of $28.14M and net income of -$452.86K for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Sanara MedTech Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

Sanara MedTech Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$28.14M$27.80M$27.55M$26.33M$25.80M$23.43M$26.31M$21.67M$20.16M$18.54M
Cost of revenue$1.98M$1.92M$1.87M$1.87M$1.94M$1.83M$2.25M$1.99M$2.01M$1.89M
Gross profit$26.16M$25.87M$25.67M$24.46M$23.87M$21.60M$24.06M$19.68M$18.15M$16.65M
Operating income$1.78M$2.65M$1.05M$2.94M$2.49M$825.53K$2.26M$778.54K-$2.88M-$1.53M
Net income-$452.86K$458.96K-$1.61M-$30.41M-$2.01M-$3.53M-$1.54M-$2.86M-$3.50M-$1.76M
Research & development$1.15M$759.59K$2.04M$1.03M$1.06M$950.36K$883.40K$783.84K$985.65K$946.30K
Weighted-average diluted sharesshares 8.66Mshares 8.99MUnavailableshares 8.94Mshares 8.93Mshares 8.57MUnavailableshares 8.52Mshares 8.47Mshares 8.42M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.05$0.05Unavailable$-3.40$-0.23$-0.41Unavailable$-0.34$-0.41$-0.21
Selling, general & administrative$22.60M$21.88M$20.08M$19.88M$19.63M$19.13M$20.22M$17.42M$18.96M$16.19M
General & administrative$5.73M$4.87MUnavailableUnavailable$3.96M$4.05MUnavailableUnavailableUnavailableUnavailable
Selling & marketing$16.87M$17.01MUnavailableUnavailable$15.68M$15.08MUnavailableUnavailableUnavailableUnavailable

Balance

Sanara MedTech Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$15.42M$13.59M$16.58M$14.94M$16.96M$20.69M$15.88M$16.28M$6.15M$2.83M
Total assets$69.15M$69.28M$72.94M$71.09M$98.77M$96.38M$88.09M$88.55M$73.38M$70.91M
Current assets$32.20M$31.20M$33.54M$31.23M$33.67M$36.84M$33.31M$31.91M$20.81M$17.19M
Total liabilities$61.21M$62.26M$67.01M$64.95M$63.38M$59.71M$49.18M$49.09M$31.98M$27.90M
Current liabilities$12.49M$13.70M$18.63M$17.36M$14.88M$13.28M$15.29M$14.34M$11.57M$12.75M
Total equity incl. NCI$7.93M$7.02M$5.93M$6.14M$35.39M$36.67M$38.91M$39.45M$41.40M$43.01M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$3.46M$3.12M$3.95M$3.39M$3.51M$3.16M$2.75M$3.01M$3.56M$4.23M
Accounts receivable$12.57M$13.62M$12.00MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Goodwill$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M$3.60M
Long-term debt$46.48M$46.23M$45.97M$45.09M$44.22M$43.40M$30.69M$30.08M$14.37M$8.77M
Accounts payable$1.40MUnavailable$2.34MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Sanara MedTech Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow$2.04M-$2.47M$3.95M$2.18M$2.66M-$2.00M$932.05K$2.05M-$1.41M-$1.59M
Capital expenditures$5.28K$43.77K$82.16K$1.06M$1.76M$1.72M$72.17K$9.10K$58.76K$65.82K
Investing cash flow-$5.28K-$43.77K-$2.45M-$3.42M-$3.93M-$5.18M-$129.99K-$6.36M-$58.76K-$65.82K
Financing cash flow-$206.48K-$475.22K$139.43K-$774.75K-$2.47M$11.99M-$1.20M$14.43M$4.79M-$658.79K
Net change in cash$1.83M-$2.98M$1.64M-$2.02M-$3.73M$4.81M-$398.89K$10.13M$3.32M-$2.32M
Stock-based compensation$1.50M$1.03M$1.18M$1.23M$1.44M$1.30M$1.20M$1.03M$1.41M$803.39K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$619.11K$587.25K$668.40K$610.90K$688.55K$1.12M$1.61M$696.89K$1.11M$1.11M

Derived

Sanara MedTech Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow$2.03M-$2.51M$3.86M$1.12M$902.65K-$3.72M$859.88K$2.04M-$1.47M-$1.66M
Gross margin93.0%93.1%93.2%92.9%92.5%92.2%91.4%90.8%90.0%89.8%
Operating margin6.3%9.5%3.8%11.2%9.6%3.5%8.6%3.6%-14.3%-8.3%
FCF margin7.2%-9.0%14.0%4.2%3.5%-15.9%3.3%9.4%-7.3%-9.0%
SBC / revenue5.3%3.7%4.3%4.7%Unavailable5.6%4.5%4.7%7.0%4.3%
Current ratio2.58x2.28x1.80x1.80x2.26x2.77x2.18x2.23x1.80x1.35x
Revenue YoY growth9.0%18.6%4.7%21.5%28.0%26.4%48.7%35.2%28.0%19.4%
Net margin-1.6%1.7%-5.8%-115.5%-7.8%-15.1%-5.8%-13.2%-17.4%-9.5%
R&D / revenue4.1%2.7%7.4%3.9%4.1%4.1%3.4%3.6%4.9%5.1%
CapEx / revenue0.0%0.2%0.3%4.0%6.8%7.4%0.3%0.0%0.3%0.4%
Long-term debt / equity5.86xUnavailable7.75x7.34xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SMTI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-05-12View SEC filing
10-K · Filed 2026-03-24View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-09-30

Difference 1602923 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2023-06-30

Difference 15592368 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.